Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many applications to the Cancer Drugs Fund have been successful in Oxford West and Abingdon; and what the financial value of those applications was.
Prior to April 2013, the Cancer Drugs Fund (CDF) was administered through clinical panels based in each strategic health authority (SHA) and data on the number of patients accessing the Fund and expenditure at constituency level were not collected. Information for the South Central SHA and England in 2010-11, 2011-12 and 2012-13 is shown below:
| Number of patients funded in 2010-111 | Amount spent 2010-11 £000 | Number of patients funded in 2011-121 | Amount spent 2011-12 £000 | Number of patients funded in 2012-131 | Amount spent 2012-13 £000 |
South Central SHA | 290 | 3,200 | 1,170 | 5,318 | 2,288 | 14,542 |
England | 2,780 | 38,524 | 11,798 | 108,327 | 15,456 | 175,334 |
Source: Information provided to the Department by SHAs
1 Some individual patients may be double-counted where a patient has received more than one drug treatment through the CDF
NHS England has had oversight of the Fund since April 2013 and publishes information on patient numbers routinely on its website at:
www.england.nhs.uk/ourwork/pe/cdf/
Information for the NHS England South region and England in 2013-14 and 2014-15 (April- September) is shown below:
| Number of patients1 funded in 2013-14 | Amount spent 2013-14 £000 | Number of patients funded in 2014-15 (April- September) | Amount spent 2013-14 £000 (April- September) |
NHS England South2 | 5,327 | _3 | 3,027 | _3 |
England | 19,560 | 230,539 | 11,308 | _3 |
Source: NHS England
1 Some individual patients may be double-counted where a patient has received more than one drug treatment through the CDF
2 Includes individual CDF request applications approved by the CDF panel in the South region
3 not available